NDAINJECTIONINJECTABLEPriority Review
Approved
Sep 1954
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ARAMINE (metaraminol bitartrate) is a parenteral sympathomimetic amine approved in 1954 for treating hypotension in acute care settings. It acts as an alpha and beta-adrenergic agonist to elevate blood pressure through vasoconstriction and increased cardiac output. This injectable is used primarily in hospital and emergency care environments for hemodynamic support.
LOE Approaching
As a 70-year-old product approaching LOE with modest commercial pressure (30 competitiveness score), this represents a legacy franchise with likely small, specialized teams focused on retention and compliance.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on ARAMINE offers stability and deep expertise in a niche acute-care franchise, but limited visibility for career advancement or skill diversification. This role suits professionals seeking operational mastery in a legacy product or transition-ready candidates preparing for LOE management.
Product Manager (Legacy)Regulatory Affairs Specialist
Worked on ARAMINE at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.